Towards Universal Access Scaling up priority HIV/AIDS interventions in the health sector, Progress Report, 2007. ,
Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, C??te d'Ivoire, AIDS, vol.17, issue.4, pp.575-584, 2003. ,
DOI : 10.1097/00002030-200303070-00013
Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa, AIDS, vol.21, issue.9, pp.1157-1164, 2007. ,
DOI : 10.1097/QAD.0b013e3281c615da
URL : https://hal.archives-ouvertes.fr/inserm-00172158
Case study country ? Cote d'Ivoire Strategies for Building National- Scale Longitudinal Patient Monitoring Systems for HIV Treatment and Care in PEPFAR Countries, 2007. ,
Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2 Infections in West African Pregnant Women, Journal of Clinical Microbiology, vol.42, issue.9, pp.4147-53, 2004. ,
DOI : 10.1128/JCM.42.9.4147-4153.2004
Impact of Vital Status Investigation Procedures on Estimates of Survival in Cohorts of HIV-Infected Patients From Sub-Saharan Africa, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.3, pp.320-323, 2004. ,
DOI : 10.1097/00126334-200403010-00015
Prognosis of HIVinfected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, Lancet, vol.360, pp.319-329, 2002. ,
Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya, AIDS, vol.20, issue.1, pp.41-49, 2006. ,
DOI : 10.1097/01.aids.0000196177.65551.ea
Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia, JAMA, vol.296, issue.7, pp.782-93, 2006. ,
DOI : 10.1001/jama.296.7.782
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet, vol.367, issue.9519, pp.1335-1377, 2006. ,
DOI : 10.1016/S0140-6736(06)68580-2
Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa, AIDS, vol.18, issue.6, pp.887-95, 2004. ,
DOI : 10.1097/00002030-200404090-00006
Adherence to Highly Active Antiretroviral Therapy Assessed by Pharmacy Claims Predicts Survival in HIV-Infected South African Adults, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.1, pp.78-84, 2006. ,
DOI : 10.1097/01.qai.0000225015.43266.46
Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance, The Lancet, vol.360, issue.9326, pp.34-40, 2002. ,
DOI : 10.1016/S0140-6736(02)09330-3
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda, The Lancet, vol.368, issue.9547, pp.1587-94, 2006. ,
DOI : 10.1016/S0140-6736(06)69118-6
Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.40, issue.3, pp.336-379, 2005. ,
DOI : 10.1097/01.qai.0000159668.80207.5b
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, pp.817-824, 2006. ,
Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, C??te d??Ivoire, AIDS, vol.17, issue.3, pp.5-15, 2003. ,
DOI : 10.1097/00002030-200317003-00002
Morbidity causes in HIV-infected adults before and after the antiretroviral treatment (ART) era in Abidjan, Côte d'Ivoire: data from the Cotrame ANRS 1203 cohort study, Antivir Ther, vol.8, p.360, 2003. ,
Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design, AIDS, vol.19, issue.18, pp.2141-2149, 2005. ,
DOI : 10.1097/01.aids.0000194802.89540.e1
Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.1, pp.14-21, 2005. ,
DOI : 10.1097/00126334-200501010-00003
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, vol.20, issue.8, pp.1181-1190, 2006. ,
DOI : 10.1097/01.aids.0000226959.87471.01
Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation, Clinical Infectious Diseases, vol.43, issue.6, pp.770-776, 2006. ,
DOI : 10.1086/507095
Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi, AIDS, vol.20, issue.18, pp.2355-60, 2006. ,
DOI : 10.1097/QAD.0b013e32801086b0
Establishment of a Public Antiretroviral Treatment Clinic for Adults in Urban Botswana: Lessons Learned, Clinical Infectious Diseases, vol.40, issue.7, pp.1041-1045, 2005. ,
DOI : 10.1086/428352
Predictors of early death in a cohort of Ethiopian patients treated with HAART, BMC Infectious Diseases, vol.37, issue.10, p.136, 2006. ,
DOI : 10.1086/379072
Mediumterm survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Antivir Ther, vol.8, pp.385-393, 2003. ,
Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control, AIDS, vol.20, issue.12, pp.1605-1617, 2006. ,
DOI : 10.1097/01.aids.0000238406.93249.cd
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort, AIDS, vol.20, issue.8, pp.1163-1172, 2006. ,
DOI : 10.1097/01.aids.0000226957.79847.d6
Physicians' Experience with the Acquired Immunodeficiency Syndrome as a Factor in Patients' Survival, New England Journal of Medicine, vol.334, issue.11, pp.701-707, 1996. ,
DOI : 10.1056/NEJM199603143341106
The relationship of clinic experience with advanced HIV and survival of women with AIDS, AIDS, vol.12, issue.4, pp.417-441, 1998. ,
DOI : 10.1097/00002030-199804000-00011
Cost-Effectiveness of HIV Treatment in Resource-Poor Settings ??? The Case of C??te d'Ivoire, New England Journal of Medicine, vol.355, issue.11, pp.1141-1153, 2006. ,
DOI : 10.1056/NEJMsa060247
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study, The Lancet, vol.363, issue.9417, pp.1253-63, 2004. ,
DOI : 10.1016/S0140-6736(04)15997-7
Adherence to Nonnucleoside Reverse Transcriptase Inhibitor???Based HIV Therapy and Virologic Outcomes, Annals of Internal Medicine, vol.146, issue.8, pp.564-73, 2007. ,
DOI : 10.7326/0003-4819-146-8-200704170-00007
Survival after ART initiation, by pre-ART CD4 count Probability (95% CI) at : Baseline CD4 count ,
Probability of being lost to follow-up after ART initiation, by type of care centre Probability (95% CI) at : Type of care centre Aconda care centre (CePReF care centre, exclusively dedicated to HIV care) Other centres (recently opened, and non exclusively dedicated to HIV care) Overall Month ,